Despite increasing evidence for a major role for sulfation in the metabolism of
lower-chlorinated polychlorinated biphenyls in vitro and in
vivo, and initial evidence for potential bioactivities of the resulting sulfate
ester metabolites, the formation of PCB sulfates in PCB exposed human populations had not
been explored. The primary goal of this study was to determine if PCB sulfates, and
potentially other conjugated PCB derivatives, are relevant classes of PCB metabolites in
the serum of humans with known exposures to PCBs. In order to detect and quantify
dichlorinated PCB sulfates in serum samples of 46 PCB-exposed individuals from either
rural or urban communities, we developed a high-resolution mass spectrometry-based
protocol using 4-PCB 11 sulfate as a model compound. The method also allowed the
preliminary analysis of these 46 human serum extracts for the presence of other
metabolites, such as glucuronic acid conjugates and hydroxylated PCBs. Sulfate ester
metabolites derived from dichlorinated PCBs were detectable and quantifiable in more than
20 % of analyzed serum samples. Moreover, we were able to utilize this method to
detect PCB glucuronides and hydroxylated PCBs, albeit at lower frequencies than PCB
sulfates. Altogether, our results provide initial evidence for the presence of PCB
sulfates in human serum. Considering the inability of previously employed analytical
protocols for PCBs to extract these sulfate ester metabolites and the concentrations of
these metabolites observed in our current study, our data support the hypothesis that
total serum levels of PCB metabolites in exposed individuals may have been underestimated
in the past.